La chaîne d'options affiche les données clés des options sur actions de Symbolic Logic à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Symbolic Logic..

Symbolic Logic (OTC:EVOL) Stock, Chaîne d'Options

Evolving Systems

Symbolic Logic Inc is a research and development organization with two significant pre-revenue focus areas that leverage the experience gained from having deployed real-time systems to over a billion real-time users at evolving.

SYMBOLIC LOGIC INC by Symbolic Logic Inc.

Symbolic Logic Inc

EVOLUTION SOLAR CORP by Evolution Solar Corp.

EVOLVA HLDG AG S/ADR by Evolva Holding AG

EVOLVE AUTO IN IND ETF UT by Evolve Automobile Innovation Index Fd

EVOLVE CRYPTOCRRECIS UTS by EVOLVE CRYPTOCURRENCIES ETF

EVOLVE ETHER ETF UNHDG UT by EVOLVE ETHER ETF

Evolent Health Inc

Evolus Inc

Evolution AB

EVOLUTION BLOCKCHAIN GRP by Evolution Blockchain Group Inc.

Evolution Blockchain Group Inc

EVOLUTION ENERGY MINERALS by EVOLUTION ENERGY MINERALS LTD

Evolution Energy Minerals Ltd

EVOLUTION MINING LTD ORD by Evolution Mining Ltd.

Evolution Mining Ltd

EVOLUTION MIN UNSP/ADR by Evolution Mining Ltd.

Evolution Petroleum Corporation, Inc. Common Stock

Evolution Petroleum Corp

EVOLUTION TECH RES INC by Evolution Technology Resources Inc.

Evolution Technology Resources Inc

EVOLUTIONARY GENOMICS INC by Evolutionary Genomics, Inc.

Evolutionary Genomics Inc

Evolv Technologies Holdings, Inc. - Class A Common Stock

Evolv Technologies Holdings Inc

Evolv Technologies Holdings, Inc. - Warrant

Evolva Holding SA

Evolva Holding SA ADR

Evolve Transition Infrastructure LP

Evolve Transition Infrastructure LP COM UNIT REPSTG LTD

News

EOLS

EVOL

CORRECTION: Evolus Ticker Is EOLS

<h3>Gainers</h3>
<ul>
<li>MedAvail Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdvl#NASDAQ">MDVL</a>) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.</li>
<li>Indonesia Energy Corporation Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/indo#NYSE">INDO</a>) gained 65.9% to close at $26.40 on continued volatility. The small-cap energy stock has surged amid strength in oil prices in recent months.</li>
<li>Houston American Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/husa#NYSE">HUSA</a>) climbed 38.5% to close at $4.86.</li>
<li>Cumulus Media Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmls#NASDAQ">CMLS</a>) shares climbed 39.9% to close at $14.21 amid report a consoritum led by Jeff Warshaw has offered to buy the company between $15-$17/share.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) climbed 36.4% to close at $2.25.</li>
<li>Marine Petroleum Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/marps#NASDAQ">MARPS</a>) gained 27.5% to settle at $9.61 on continued volatility. The nano-cap energy stock has surged amid strength in oil prices in recent months, but it has been trending lower in recent weeks.</li>
<li>SCWorx Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/worx#NASDAQ">WORX</a>) gained 25.8% to close at $1.12 as the company reached an agreement in principle with SEC staff to resolve previously disclosed SEC matter.</li>
<li>Clarus Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crxt#NASDAQ">CRXT</a>) climbed 25.3% to close at $1.24 on above-average volume.</li>
<li>Mexco Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mxc#NYSE">MXC</a>) rose 20.8% to close at $19.34.</li>
<li>Lyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyra#NASDAQ">LYRA</a>) gained 20.4% to close at $7.51.</li>
<li>NextDecade Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/next#NASDAQ">NEXT</a>) jumped 19.5% to close at $7.37.</li>
<li>Trevi Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trvi#NASDAQ">TRVI</a>) climbed 18% to close at $3.28. Trevi Therapeutics 10%+ shareholder Scott Sandell reported the purchase of 6,580,526 shares at an average price of $1.90/share in Form 4 filing.</li>
<li>Airgain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/airg#NASDAQ">AIRG</a>) gained 18.9% to close at $8.32 after the company was selected by a US-based water utility company to improve the connectivity of its fleet. No terms were disclosed.</li>
<li>Cardiol Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdl#NASDAQ">CRDL</a>) jumped 17.8% to close at $2.05.</li>
<li>Lexaria Bioscience Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lexx#NASDAQ">LEXX</a>) rose 17.1% to close at $3.83 after the company reported safety and efficacy findings from its simulated pulmonary hypertension clinical study HYPER-H21-3.</li>
<li>Renren Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/renn#NYSE">RENN</a>) shares climbed 16.7% to close at $26.78. Renren recently signed a Software License and Distribution Agreement with Guangzhou Yupu Software Technology Co Ltd.</li>
<li>Tantech Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tanh#NASDAQ">TANH</a>) gained 16.3% to settle at $0.50.</li>
<li>Verastem, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vstm#NASDAQ">VSTM</a>) gained 15.7% to close at $1.77 after RBC Capital initiated coverage on the stock with an Outperform rating and a $5 price target.</li>
<li>Inozyme Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inzy#NASDAQ">INZY</a>) gained 15.5% to close at $4.26. The company announced an underwritten offering of 16,276,987 shares of its common stock at $3.69 per share for gross proceeds of ~$73 million.</li>
<li>Borqs Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brqs#NASDAQ">BRQS</a>) jumped 15.3% to close at $0.1963 after the company signed a set of revised licensing agreements with Qualcomm, including a 5G licensing agreement to design and manufacture 5G products based on the Qualcomm latest technologies.</li>
<li>Amesite Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) jumped 15.3% to close at $0.6699.</li>
<li>CoreCivic, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cxw#NYSE">CXW</a>) rose 15% to close at $13.45 after Wedbush upgraded the stock from Neutral to Outperform and announced a $17 price target.</li>
<li>RISE Education Cayman Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/redu#NASDAQ">REDU</a>) rose 14.6% to close at $1.26.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clrb#NASDAQ">CLRB</a>) jumped 14.3% to close at $0.6886. Cellectar Biosciences, last month, reported better-than-expected Q4 EPS results.</li>
<li>Imperial Petroleum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impp#NASDAQ">IMPP</a>) climbed 14.1% to close at $1.46.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) gained 12.7% to settle at $1.24.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>Genius Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gns#NYSE">GNS</a>) shares dipped 59.1% to close at $7.95 on continued volatility following the stock&#39;s recent IPO.</li>
<li>Histogen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsto#NASDAQ">HSTO</a>) shares fell 36.4% to close at $0.2468 on above-average volume.</li>
<li>Singularity Future Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgly#NASDAQ">SGLY</a>) fell 23.2% to close at $6.46.</li>
<li>Protagonist Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptgx#NASDAQ">PTGX</a>) fell 21.8% to close at $19.95 after the company received a letter from the FDA indicating the agency&#39;s intent to rescind Breakthrough Therapy Designation for the company&#39;s rusfertide product candidate in polycythemia vera.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) fell 20.2% to close at $0.9017. Guardforce AI regained compliance with Nasdaq listing requirements.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lixt#NASDAQ">LIXT</a>) dipped 19.9% to close at $1.57. LIXTE Biotechnology recently announced a $5.8 million registered direct offering priced at-the-market.</li>
<li>Pyxis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyxs#NASDAQ">PYXS</a>) fell 19.4% to close at $3.65.</li>
<li>Forge Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frge#NYSE">FRGE</a>) fell 19.3% to close at $13.56.</li>
<li>Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) dropped 18.5% to settle at $1.45 after the company announced it has notified Nasdaq of its intention to voluntarily withdraw its common stock.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) fell 17.9% to close at $1.65 following recent IPO.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dropped 17.7% to close at $1.81. Shineco announced entering into a securities purchase agreement with gross proceeds of $2.2 million.</li>
<li>ION Geophysical Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/io#NYSE">IO</a>) dropped 17.5% to close at $0.3492 after the company filed for voluntary Chapter 11 relief in the U.S. Bankruptcy Court.</li>
<li>ATRenew Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rere#NASDAQ">RERE</a>) declined 17.4% to close at $2.62.</li>
<li>Ayala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ayla#NASDAQ">AYLA</a>) dropped 17% to close at $3.07.</li>
<li>Cambium Networks Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmbm#NASDAQ">CMBM</a>) dipped 16.6% to close at $16.95 after the company cut its Q1 sales guidance below analyst estimates.</li>
<li>Zymergen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zy#NASDAQ">ZY</a>) shares fell 16.6% to close at $1.76.</li>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) fell 16.5% to close at $1.27 a.</li>
<li>Burning Rock Biotech Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnr#NASDAQ">BNR</a>) dipped 16% to close at $7.23.</li>
<li>American Rebel Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/areb#NASDAQ">AREB</a>) dropped 16% to close at $1.47.</li>
<li>IsoPlexis Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iso#NASDAQ">ISO</a>) dipped 15.4% to close at $2.30.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) fell 15.3% to close at $4.03.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) fell 15.3% to close at $4.20. Biofrontera recently announced the FDA approval of its cGMP laboratory in Germany for batch control and stability testing of Ameluz.</li>
<li>Artelo Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/artl#NASDAQ">ARTL</a>) shares fell 15% to close at $0.43. Artelo Biosciences recently reported pre-clinical results for its G-Protein Coupled Receptor for the treatment of cancer-related anorexia.</li>
<li>Cerberus Cyber Sentinel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) fell 14.7% to close at $4.51.</li>
<li>Esports Entertainment Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) shares fell 14.2% to close at $0.6292. Pulse Biosciences recently reported worse-than-expected Q4 EPS and sales results.</li>
</ul>

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

AIRG

AMST

APCX

AREB

ARTL

AYLA

BFRI

Borqs Technologies, Inc. - Ordinary Shares

BRQS

CISO

CLRB

CMBM

CMLS

CRDL

CRXT

FRGE

GFAI

GMBL

HSTO

HUSA

IMPP

INDO

INZY

LEXX

LIXT

LYRA

MARPS

MDVL

PHAS

PTGX

PYXS

REDU

RENN

RERE

RVSN

SBFM

SGLY

SISI

SYTA

TANH

TRVI

VSTM

WORX

51 Biggest Movers From Thursday

WIIM

Evolving Systems shares are trading lower after the company announced it has notified Nasdaq of its intention to voluntarily withdraw its common stock.

<h3>Gainers</h3>
<ul>
<li>Borqs Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRQS#NASDAQ">BRQS</a>) shares moved upwards by 29.8% to $0.22 during Thursday's regular session. As of 13:30 EST, this security is trading at a volume of 214.4 million shares, making up 2388.4% of its average full-day volume over the last 100 days. The company's market cap stands at $35.8 million. </li>
<li>AppTech Payments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APCX#NASDAQ">APCX</a>) shares moved upwards by 22.89% to $2.04. The current volume of 256.5K shares is 218.7% of AppTech Payments's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $33.3 million. </li>
<li>Renren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RENN#NYSE">RENN</a>) shares rose 16.52% to $26.73. Trading volume for this security as of 13:30 EST is 370.6K, which is 495.6% of its average full-day volume over the last 100 days. The company's market cap stands at $642.0 million. </li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) stock moved upwards by 16.1% to $8.13. As of 13:30 EST, Airgain's stock is trading at a volume of 1.1 million, which is 1971.7% of its average full-day volume over the last 100 days. The company's market cap stands at $82.7 million. </li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) shares rose 14.69% to $0.36. Powerbridge Technologies's stock is trading at a volume of 34.5 million shares as of 13:30 EST. This is 1551.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.9 million. </li>
<li>Alpine 4 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALPP#NASDAQ">ALPP</a>) shares rose 11.86% to $1.14. As of 13:30 EST, Alpine 4 Holdings's stock is trading at a volume of 763.6K, which is 58.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $209.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETXP#NASDAQ">CETXP</a>) stock fell 23.2% to $1.15 during Thursday's regular session. </li>
<li>Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) stock declined by 20.91% to $1.4. The current volume of 503.2K shares is 599.6% of Evolving Systems's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $17.2 million. </li>
<li>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) stock declined by 18.21% to $16.62. Trading volume for this security as of 13:30 EST is 681.6K, which is 358.7% of its average full-day volume over the last 100 days. The company's market cap stands at $444.4 million. </li>
<li>Sonic Foundry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFO#NASDAQ">SOFO</a>) shares declined by 11.57% to $2.6. As of 13:30 EST, this security is trading at a volume of 92.3K shares, making up 313.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.6 million. </li>
<li>Cerberus Cyber Sentinel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares fell 9.27% to $4.8. The current volume of 126.9K shares is 11.7% of Cerberus Cyber Sentinel's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $646.3 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) shares fell 8.67% to $0.53. As of 13:30 EST, this security is trading at a volume of 70.2K shares, making up 70.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALPP

CETXP

OBLG

PBTS

SOFO

12 Information Technology Stocks Moving In Thursday's Intraday Session

The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Scott&#39;s Liquid Gold </h2>
<ul>
<li>The Trade: Scott&#39;s Liquid Gold-Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/slgd#OTC">SLGD</a>) 10% owner Mark E Goldstein <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 127,000 shares </a> at an average price of $0.98. To acquire these shares, it cost $124.46 thousand.</li>
<li>What&rsquo;s Happening: The company recently posted a net loss of $7.3 million in Q4.</li>
<li>What Scott&#39;s Liquid Gold Does: Scott&#39;s Liquid Gold Inc develop, market, and sell high-quality, high-value household and personal care products. Its business is divided into two operating segments: household products and personal care products.</li>
</ul>
<h2>Neuronetics </h2>
<ul>
<li>The Trade: Neuronetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stim#NASDAQ">STIM</a>) 10% owner Cannell Capital Llc <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 265,305 shares </a> at an average price of $3.00. The insider spent around $795.7 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Neuronetics, last month, reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 million and the consensus of $14.43 million.</li>
<li>What Neuronetics Does: Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/04/26421307/executives-buy-over-17m-of-3-stocks">Also check this: Executives Buy Over $17M Of 3 Stocks </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h2>Movano </h2>
<ul>
<li>The Trade: Movano Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/move#NASDAQ">MOVE</a>) Director Emily Fairbairn <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 8,011 shares </a> at an average price of $2.80. To acquire these shares, it cost around $22.46 thousand.</li>
<li>What&rsquo;s Happening: Movano S-3 showed registration for $100 million mixed securities shelf offering.</li>
<li>What Movano Does: Movano, based in Pleasanton, California, develops a smart wearable and continuous glucose monitoring device.</li>
</ul>
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 40,524 shares </a> at an average price of $1.81. The insider spent $73.35 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s shares have tumbled around 15% since the start of the year.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>

Long Ideas

Insider Trades

MOVE

SLGD

STIM

Executives Buy Around $1M Of 4 Penny Stocks

US stock futures traded sharply higher this morning after the Dow Jones dropped more than 180 points on Tuesday. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 6,117 shares </a> at an average price of $1.82. To acquire these shares, it cost $11.13 thousand.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock dropped 5% over the last month.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<h2>Velodyne Lidar </h2>
<ul>
<li>The Trade: Velodyne Lidar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vldr#NASDAQ">VLDR</a>) Director Ernest Maddock <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 20,000 shares </a> at an average price of $2.50. The insider spent around $49.9 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company recently posted upbeat quarterly sales.</li>
<li>What Velodyne Lidar Does: Velodyne Lidar Inc provides smart, powerful lidar solutions.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/03/25944581/insiders-buy-around-2-8m-of-3-stocks">Also check this: Insiders Buy Around $2.8M Of 3 Stocks</a>
<h2>a.k.a. Brands Holding </h2>
<ul>
<li>The Trade: a.k.a. Brands Holding Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aka#NYSE">AKA</a>) Director Myles McCormick <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $4.28. To acquire these shares, it cost around $42.8 thousand.</li>
<li>What&rsquo;s Happening: A.K.A. Brands recently issued Q1 sales guidance below analyst estimates.</li>
<li>What a.k.a. Brands Holding Does: a.k.a. Brands Holding Corp is a portfolio of online fashion brands built for the next generation of consumers.</li>
</ul>
<h2>Martin Midstream Partners </h2>
<ul>
<li>The Trade: Martin Midstream Partners L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmlp#NASDAQ">MMLP</a>) Director Ruben S Martin <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 9,278 shares </a> at an average price of $3.24. The insider spent $30.1 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Martin Midstream Partners, last month, reported FY21 sales of $882.4 million.</li>
<li>What Martin Midstream Partners Does: Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region.</li>
</ul>
<h2>Archer Aviation </h2>
<ul>
<li>The Trade: Archer Aviation Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/achr#NYSE">ACHR</a>) 10% owner Marc E Lore <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 746,183 shares </a> at an average price of $3.02. The insider spent $2.25 million to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock has dropped around 47% since the start of the year.</li>
<li>What Archer Aviation Does: Archer Aviation Inc advances the benefits of sustainable air mobility. It is creating the electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.</li>
</ul>

ACHR

MMLP

VLDR

Executives Buy Over $2.3M Of 5 Penny Stocks

<h3>Gainers</h3>
<ul>
<li>MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) shares rose 11.0% to $312.8 during Tuesday's after-market session. This security traded at a volume of 247.0K shares come close, making up 21.1% of its average volume over the last 100 days. The company's market cap stands at $20.8 billion. The company's, Q4 earnings came out today. </li>
<li>Inpixon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INPX#NASDAQ">INPX</a>) shares moved upwards by 7.89% to $0.41. Trading volume for this security closed at 267.8K, accounting for 21.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.0 million. </li>
<li>Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) stock rose 5.51% to $1.53. The company's market cap stands at $135.1 million. As per the news, the Q4 earnings report came out today. </li>
<li>Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) shares moved upwards by 5.4% to $1.95. The market value of their outstanding shares is at $23.9 million. </li>
<li>Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) shares moved upwards by 4.98% to $6.74. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) stock rose 4.91% to $91.0. The market value of their outstanding shares is at $7.5 billion. As per the news, the Q2 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) stock fell 16.6% to $4.94 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 66.3K shares, which is 4.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $640.3 million. As per the news, the Q4 earnings report came out today. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) stock decreased by 9.77% to $3.05. The market value of their outstanding shares is at $13.6 million. </li>
<li>Datasea (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTSS#NASDAQ">DTSS</a>) shares declined by 8.27% to $2.33. The company's market cap stands at $56.4 million. </li>
<li>Safe-T Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFET#NASDAQ">SFET</a>) stock declined by 7.41% to $1.0. Trading volume for this security closed at 73.4K, accounting for 21.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.1 million. </li>
<li>SilverSun Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNT#NASDAQ">SSNT</a>) stock declined by 5.56% to $4.08. At the close, SilverSun Technologies's trading volume reached 82.7K shares. This is 43.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.9 million. </li>
<li>GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) shares declined by 3.87% to $54.26. The company's market cap stands at $28.8 billion. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DTSS

GWRE

INPX

LEDS

RSKD

SFET

SNCR

SSNT

YEXT

12 Information Technology Stocks Moving In Tuesday's After-Market Session

China&rsquo;s official NBS manufacturing PMI rose to 50.2 in February from January&#39;s figure of 50.1. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Avalo Therapeutics </h2>
<ul>
<li>The Trade: Avalo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avtx#NASDAQ">AVTX</a>) Director Steven Boyd <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 140,000 shares </a> at an average price of $0.80. To acquire these shares, it cost $111.81 thousand.</li>
<li>What&rsquo;s Happening: Avalo Therapeutics recently promoted Garry Neil to Chief Executive Officer.</li>
<li>What Avalo Therapeutics Does: Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.</li>
</ul>
<h2>Outlook Therapeutics </h2>
<ul>
<li>The Trade: Outlook Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otlk#NASDAQ">OTLK</a>) Director Kurt Hilzinger <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 47,160 shares </a> at an average price of $1.48. The insider spent around $69.69 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Outlook Therapeutics, last month, posted a Q1 loss of $0.08 per share.</li>
<li>What Outlook Therapeutics Does: Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25834898/insiders-buy-around-98m-of-3-stocks">Also check this: Insiders Buy Around $98M Of 3 Stocks</a>
<h2>ReWalk Robotics </h2>
<ul>
<li>The Trade: ReWalk Robotics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rwlk#NASDAQ">RWLK</a>) 10% owner Lind Global MacRo Fund Lp <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 512,939 shares </a> at an average price of $1.04. To acquire these shares, it cost around $531.54 thousand.</li>
<li>What&rsquo;s Happening: ReWalk Robotics recently posted Q4 sales of $1.20 million.</li>
<li>What ReWalk Robotics Does: ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again.</li>
</ul>
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 26,143 shares </a> at an average price of $1.77. The insider spent $46.16 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock dropped 14% over the past six months.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>

AVTX

OTLK

RWLK

4 Penny Stocks Insiders Are Buying

The economic sentiment indicator in the Eurozone rose to a 3-month high level of 114 in February, surpassing market estimates of 113.1. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Crexendo </h2>
<ul>
<li>The Trade: Crexendo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxdo#NASDAQ">CXDO</a>) CEO Steven G Mihaylo <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 3,000 shares </a> at an average price of $4.45. To acquire these shares, it cost $13.36 thousand.</li>
<li>What&rsquo;s Happening: Crexendo recently declared a quarterly dividend of $.005 per common share.</li>
<li>What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.</li>
</ul>
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 70,628 shares </a> at an average price of $1.78. The insider spent around $125.83 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Evolving Systems recently reported a strategic collaboration with Zain Saudi Arabia to deliver a key component of its new Loyalty offering.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25834898/insiders-buy-around-98m-of-3-stocks">Also check this: Insiders Buy Around $98M Of 3 Stocks</a>
<h2>Charles &amp; Colvard </h2>
<ul>
<li>The Trade: Charles &amp; Colvard, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cthr#NASDAQ">CTHR</a>) CEO and President Don Oconnell <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $1.82. To acquire these shares, it cost around $18.2 thousand.</li>
<li>What&rsquo;s Happening: The company recently posted downbeat quarterly earnings.</li>
<li>What Charles &amp; Colvard Does: Charles &amp; Colvard Ltd manufactures, markets and distributes finished jewellery which also includes moissanite gemstone in the jewellery market.</li>
</ul>
<h2>Doma Holdings </h2>
<ul>
<li>The Trade: Doma Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/doma#NYSE">DOMA</a>) Director Mark Ein <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 332,970 shares </a> at an average price of $2.40. The insider spent $799.13 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Doma recently reported Q4 earnings results.</li>
<li>What Doma Holdings Does: Doma Holdings Inc is architecting the future of real estate transactions. The company uses machine intelligence and its patented technology solutions to transform residential real estate, making closings instant and affordable.</li>
</ul>
<h2>Sensei Biotherapeutics </h2>
<ul>
<li>The Trade: Sensei Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snse#NASDAQ">SNSE</a>) Director James Peyer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 17,500 shares </a> at an average price of $3.65. The insider spent $63.95 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock dropped around 39% year-to-date.</li>
<li>What Sensei Biotherapeutics Does: Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer.</li>
</ul>

CTHR

CXDO

DOMA

SNSE

Executives Buy Around $1M Of 5 Penny Stocks

Management

Evolving Systems 10%+ Owner Karen Singer Reported Purchase of 140,111 Shares @ Avg Price of $1.81/Share in Form 4 Filing on Monday

Although gold prices traded slightly lower to below $1,820 an ounce on Tuesday ahead of US inflation data due later in the week, there were a few notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Evolving Systems <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 12,598 shares </a> at an average price of $1.85. To acquire these shares, it cost $23.25 thousand.</li>
<li>What&rsquo;s Happening: Evolving Systems recently reported a strategic collaboration with Zain Saudi Arabia to deliver a key component of its new Loyalty offering.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<h2>Cyclo Therapeutics </h2>
<ul>
<li>The Trade: Cyclo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyth#NASDAQ">CYTH</a>) CEO N. Scott Fine <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,334 shares </a> at an average price of $3.58. The insider spent around $37 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Cyclo Therapeutics recently filed for U.S. patent titled &#39;Methods For Treating Alzheimer&#39;s Disease.&#39;</li>
<li>What Cyclo Therapeutics Does: Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25472919/paypal-and-3-other-stocks-bought-by-insiders">Also check this: PayPal And 3 Other Stocks Bought By Insiders </a>
<h2>Genworth Financial </h2>
<ul>
<li>The Trade: Genworth Financial, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gnw#NYSE">GNW</a>) Director Robert Restrepo Jr <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 50,000 shares </a> at an average price of $3.93. To acquire these shares, it cost $196.65 thousand.</li>
<li>What&rsquo;s Happening: The company recently posted upbeat quarterly earnings.</li>
<li>What Genworth Financial Does: Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products.</li>
</ul>
<h2>loanDepot </h2>
<ul>
<li>The Trade: loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) CEO Anthony Li Hsieh <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,584,611 shares </a> at an average price of $3.68. The insider spent $5.83 million to buy those shares.</li>
<li>What&rsquo;s Happening: LoanDepot recently reported worse-than-expected Q4 EPS results.</li>
<li>What loanDepot Does: loanDepot Inc was incorporated in Delaware on July 10, 2015. The Company provides nonbank consumer lending solutions for individuals in the United States.</li>
</ul>
<h2>Regulus Therapeutics </h2>
<ul>
<li>The Trade: Regulus Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgls#NASDAQ">RGLS</a>) Chief Scientific Officer Denis Drygin <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 23,314 shares </a> at an average price of $0.23. The insider spent $5.36 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Regulus Therapeutics recently completed a pre-investigational new drug (Pre-IND) meeting with the FDA to obtain input on the Company&#39;s RGLS8429 for Autosomal Dominant Polycystic Kidney Disease (ADPKD).</li>
<li>What Regulus Therapeutics Does: Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases.</li>
</ul>

CYTH

RGLS

Executives Buy Over $6M Of 5 Penny Stocks

Although producer prices in the Eurozone surged 26.2% year-over-year in December, hitting the highest level on record, there were a few notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,164,870 shares </a> at an average price of $2.31. To acquire these shares, it cost $2.69 million.</li>
<li>What&rsquo;s Happening: Evolving Systems reported a strategic collaboration with Zain Saudi Arabia to deliver a key component of its new Loyalty offering.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<h2>ServiceSource International </h2>
<ul>
<li>The Trade: ServiceSource International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srev#NASDAQ">SREV</a>) 10% owner Jonathan Brolin <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 48,741 shares </a> at an average price of $1.00. The insider spent $48.74 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock fell around 1% over the previous month.</li>
<li>What ServiceSource International Does: ServiceSource International Inc is a provider of customer and revenue lifecycle management solutions.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25389398/insiders-buying-charter-communications-and-3-more-stocks">Also check this: Insiders Buying Charter Communications And 3 More Stocks </a>
<h2>MannKind </h2>
<ul>
<li>The Trade: MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) Chief People &amp; Workplace Officer Stuart Tross <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 4,254 shares </a> at an average price of $3.17. To acquire these shares, it cost $13.49 thousand.</li>
<li>What&rsquo;s Happening: MannKind extended its collaboration with Thirona Bio, Inc. with the purchase of a second convertible note issued by Thirona.</li>
<li>What MannKind Does: MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.</li>
</ul>
<h2>BitNile Holdings </h2>
<ul>
<li>The Trade: BitNile Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nile#NYSE">NILE</a>) Executive Chairman Milton C. Ault III <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 40,000 shares </a> at an average price of $0.94. The insider spent $37.74 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: BitNile issued an unaudited update on Bitcoin production and miner installation.</li>
<li>What BitNile Does: BitNile Holdings Inc is engaged in providing Bitcoin mining, data center operations, and decentralized finance (DeFi) initiatives.</li>
</ul>

MNKD

NILE

SREV

Executives Buy Over $2.7M Of 4 Penny Stocks

Gainers Flex (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flex#NASDAQ">FLEX</a>) shares rose 6.9% to $17.9 during Thursday&#39;s pre-market session. The market value of their outstanding shares is at $8.4 billion. MICT (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mict#NASDAQ">MICT</a>) shares moved upwards by 6.27% to $0.69. The
<h3>Gainers</h3>
<ul>
<li>Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) shares rose 6.9% to $17.9 during Thursday&#39;s pre-market session. The market value of their outstanding shares is at $8.4 billion.</li>
<li>MICT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MICT#NASDAQ">MICT</a>) shares moved upwards by 6.27% to $0.69. The market value of their outstanding shares is at $85.0 million.</li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) shares moved upwards by 3.16% to $0.42. The market value of their outstanding shares is at $23.8 million.</li>
<li>Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) shares increased by 2.03% to $2.01. The company&#39;s market cap stands at $24.6 million.</li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25389398/insiders-buying-charter-communications-and-3-more-stocks">Check out this: Insiders Buying Charter Communications And 3 More Stocks</a>
<h3>Losers</h3>
<ul>
<li>OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) stock declined by 11.0% to $1.94 during Thursday&#39;s pre-market session. The market value of their outstanding shares is at $23.5 million.</li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) stock declined by 9.62% to $1.88. The company&#39;s market cap stands at $15.5 million.</li>
<li>Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) stock fell 9.04% to $3.02. The company&#39;s market cap stands at $75.8 million.</li>
<li>Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) stock declined by 8.87% to $92.0. The market value of their outstanding shares is at $6.6 billion. As per the news, the Q2 earnings report came out today.</li>
<li>Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) stock declined by 7.98% to $64.43. The market value of their outstanding shares is at $30.9 billion.</li>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) shares decreased by 7.28% to $3.06. The market value of their outstanding shares is at $435.8 million. See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

EVLV

FLEX

LITE

MICT

USIO

UTME

10 Information Technology Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) shares increased by 11.3% to $18.64 during Wednesday's after-market session. This security traded at a volume of 62.4K shares come close, making up 1.5% of its average volume over the last 100 days. The company's market cap stands at $8.7 billion. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock increased by 5.76% to $1.1. Digital Ally's trading volume hit 68.3K shares by close, accounting for 4.7% of its average volume over the last 100 days. The company's market cap stands at $57.9 million. </li>
<li>8x8 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NYSE">EGHT</a>) stock increased by 4.15% to $15.65. At the close, 8x8's trading volume reached 196.2K shares. This is 12.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion. The company's, Q3 earnings came out today. </li>
<li>Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) shares rose 4.06% to $2.05. Today's trading volume for this security ended up closing at 92.4K shares, which is 111.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $25.1 million. </li>
<li>Triterras (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIT#NASDAQ">TRIT</a>) shares moved upwards by 3.65% to $1.7. The market value of their outstanding shares is at $141.4 million. </li>
<li>MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) shares rose 2.65% to $62.62. The market value of their outstanding shares is at $4.8 billion. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) shares declined by 9.5% to $63.39 during Wednesday's after-market session. Trading volume for this security closed at 182.6K, accounting for 3.0% of its average full-day volume over the last 100 days. The company's market cap stands at $30.4 billion. </li>
<li>Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares decreased by 9.44% to $130.0. Trading volume for this security closed at 100.0K, accounting for 6.9% of its average full-day volume over the last 100 days. The company's market cap stands at $14.3 billion. As per the press release, Q3 earnings came out today. </li>
<li>Matterport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTTR#NASDAQ">MTTR</a>) shares decreased by 8.26% to $8.0. At the close, Matterport's trading volume reached 320.3K shares. This is 3.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.0 billion. </li>
<li>Digital Turbine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) shares fell 6.42% to $41.0. The company's market cap stands at $3.9 billion. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) stock fell 6.25% to $9.0. The company's market cap stands at $109.0 million. </li>
<li>Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares fell 5.67% to $6.33. The company's market cap stands at $262.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APPS

CLSK

DGLY

EGHT

MTTR

QRVO

TRIT

VRAR

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Germany&rsquo;s economy contracted 0.7% on quarter during the last three months of 2021, compared to analysts&rsquo; views of a 0.3% drop, sending the German DAX index lower by more than 2% on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>ReWalk Robotics </h2>
<ul>
<li>The Trade: ReWalk Robotics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rwlk#NASDAQ">RWLK</a>) 10% owner Lind Global MacRo Fund Lp <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 31,538 shares </a> at an average price of $1.08. To acquire these shares, it cost $34.02 thousand.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock dropped about 18% over the past month.</li>
<li>What ReWalk Robotics Does: ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again.</li>
</ul>
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 53,939 shares </a> at an average price of $1.86. The insider spent $100.4 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Evolving Systems, last month, announced a collaboration with Amdocs to provide loyalty and campaign capabilities for new Amdocs Digital Brands SaaS Suite.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<h2>Sensei Biotherapeutics </h2>
<ul>
<li>The Trade: Sensei Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snse#NASDAQ">SNSE</a>) 10% owner Cambrian Biopharma Inc <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 50,000 shares </a> at an average price of $4.72. To acquire these shares, it cost $235.82 thousand.</li>
<li>What&rsquo;s Happening: Sensei Biotherapeutics recently named Erin Colgan as CFO.</li>
<li>What Sensei Biotherapeutics Does: Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer.</li>
</ul>
<a href="https://www.benzinga.com/news/22/01/25258170/4-stocks-insiders-are-selling-halliburton-civeo-and-more">Also check out these stocks insiders are selling</a>

3 Penny Stocks Insiders Are Buying: ReWalk Robotics, Evolving Systems And More

The US economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>OpGen </h2>
<ul>
<li>The Trade: OpGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opgn#NASDAQ">OPGN</a>) Chief Operating Officer Johannes Bacher <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 25,000 shares </a> at an average price of $0.85. To acquire these shares, it cost $21.25 thousand.</li>
<li>What&rsquo;s Happening: OpGen recently said it sees preliminary FY21 sales of $4.3 million.</li>
<li>What OpGen Does: OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease.</li>
</ul>
<h2>Red Cat Holdings </h2>
<ul>
<li>The Trade: Red Cat Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcat#NASDAQ">RCAT</a>) Director Joseph David Freedman <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,500 shares </a> at an average price of $1.70. The insider spent $2.55 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock tumbled around 50% over the past six months.</li>
<li>What Red Cat Does: Red Cat Holdings Inc is a provider of secure blockchain-based distributed storage, analytics, and SaaS for the drone industry.</li>
</ul>
<h2>Regulus Therapeutics </h2>
<ul>
<li>The Trade: Regulus Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgls#NASDAQ">RGLS</a>) President and CEO Joseph Hagan <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 100,000 shares </a> at an average price of $0.22. To acquire these shares, it cost $21.52 thousand.</li>
<li>What&rsquo;s Happening: Regulus Therapeutics recently completed a pre-investigational new drug (Pre-IND) meeting with the FDA to obtain input on the Company&#39;s RGLS8429 for Autosomal Dominant Polycystic Kidney Disease (ADPKD).</li>
<li>What Regulus Therapeutics Does: Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases.</li>
</ul>
<a href="https://www.benzinga.com/news/22/01/25230910/3-stocks-insiders-are-selling-state-street-playa-hotels-resorts-and-more">Check out these stocks insiders are selling</a>
<h2>Evolving Systems </h2>
<ul>
<li>The Trade: Evolving Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) 10% owner Karen Singer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 170,218 shares </a> at an average price of $1.85. The insider spent $314.12 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s shares tumbled around 17% over the previous montj.</li>
<li>What Evolving Systems Does: Evolving Systems Inc provides real-time digital engagement solutions and services. It offers services to the wireless carrier and consumer financial services markets.</li>
</ul>
<h2>Crexendo </h2>
<ul>
<li>The Trade: Crexendo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxdo#NASDAQ">CXDO</a>) CEO Steven G Mihaylo <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 3,000 shares </a> at an average price of $3.93. The insider spent $11.8 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: The company was recently awarded 2021 TMC Labs Innovation Award for its VIP Platform..</li>
<li>What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.</li>
</ul>

OPGN

RCAT

5 Penny Stocks Insiders Are Buying: OpGen, Regulus Therapeutics And More

Evolving Systems,&nbsp;Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>), a leader in real-time digital engagement, has announced a collaboration with Amdocs to deliver optional capabilities for the new Amdocs Digital Brands Suite-as-a-Service offering, which enables CSPs to create game-changing digital experiences for their digital brand customers. Evolving Systems is one of several suite partners and the company will deliver loyalty and campaigns capabilities for the suite customers. 
&nbsp;
The cloud-based software-as-a-service business suite enables digital brands to introduce experiences that are simple and faster than ever before, with a &lsquo;pay-as-you-grow&#39; business model allowing for flexible growth without large commitments. It supports a market in which digital communications brands must deliver unique and dynamic digital experiences for their end users while at the same time maintaining lean back-end operations. With an end-user community of increasingly digital-savvy consumers, as well as other specific segments with innovative propositions, digital brands can enjoy high customer satisfaction and growth if they can access the solutions required to support their strategies.
The combination of the Amdocs Digital Brands Suite and Evolving Systems&#39; loyalty and campaigns capabilities will help customers improve customer experience and reduce churn through:
<ul>
<li>More personalized and relevant engagements with &quot;Next Best Offer&quot;</li>
<li>Gamification of customer engagements</li>
<li>Leveraging and monetizing third-parties for example introducing 3rd&nbsp;party vouchers</li>
<li>Reduction in churn through increased stickiness with Next Best Offers</li>
</ul>
&quot;We are extremely excited to provide an important value to Amdocs&#39; Digital Brands Suite offering through Evolving Systems&#39; expertise in loyalty and campaign management. Service providers around the world are introducing standalone, digital brands that provide superb experience through innovation and agility, while maintaining very agile operations,&quot; said Adhish Kulkarni, SVP CVM &amp; Loyalty. &quot;The combination of Amdocs&#39; suite with Evolving Systems&#39; capabilities enables those providers to improve their customer experience even further, without the IT hassle.&quot;

Contracts

Evolving Systems Collaborates With Amdocs To Provide Loyalty And Campaign Capabilities For New Amdocs Digital Brands SaaS Suite; Terms Not Disclosed

Evolving Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOL#NASDAQ">EVOL</a>) reported quarterly earnings of $0.02 per share. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported $6.97 million in sales this quarter. This is a 2.95 percent increase over sales of $6.77 million the same period last year.

Earnings

Evolving Systems Q3 EPS $0.02 Down From $0.03 YoY, Sales $6.97M Up From $6.77M YoY

<h3>Gainers</h3>
<ul>
<li>Valneva SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/valn#NASDAQ">VALN</a>) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.</li>
<li>Progenity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prog#NASDAQ">PROG</a>) rose 39.7% to close at $2.99. Benzinga recently highlighted stock as a top 5 short squeeze candidate.</li>
<li>MeiraGTx Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgtx#NASDAQ">MGTX</a>) jumped 30% to close at $18.56.</li>
<li>Evolving Systems, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evol#NASDAQ">EVOL</a>) jumped 24.1% to settle at $2.78 after the company announced it will sell its activation and marketing businesses to PartnerOne Capital for $40 million.</li>
<li>Peabody Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/btu#NYSE">BTU</a>) jumped 23.2% to settle at $19.66. Peabody said it sees preliminary Q3 sales of $670 million to $690 million.</li>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) gained 21.2% to close at $4.00 after the company earlier announced it has surpassed 10 million viewers across all platforms since Jul. 1.</li>
<li>EuroDry Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edry#NASDAQ">EDRY</a>) jumped 20.1% to settle at $30.50.</li>
<li>Aerovate Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avte#NASDAQ">AVTE</a>) shares gained 19.5% to close at $16.89 after declining around 19% on Friday.</li>
<li>Independence Contract Drilling, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/icd#NYSE">ICD</a>) rose 19.5% to close at $5.45.</li>
<li>FuelCell Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fcel#NASDAQ">FCEL</a>) shares climbed 18.3% to settle at $8.74.</li>
<li>Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) climbed 17.5% to close at $28.25. Jana Partners LLC, an activist investment firm founded by hedge fund executive Barry Rosenstein, has taken a stake in Macy&rsquo;s and has called on the company&rsquo;s leadership to spin off its e-commerce operations.</li>
<li>Agile Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agrx#NASDAQ">AGRX</a>) climbed 16.7% to close at $0.8871. The company said Executive Edelman Joseph bought 8.42 million shares at average price of $0.58.</li>
<li>Horizon Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzn#NYSE">HZN</a>) gained 16.5% to settle at $8.34.</li>
<li>Huadi International Group Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hudi#NASDAQ">HUDI</a>) surged 16.3% to close at $8.49.</li>
<li>Lightbridge Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltbr#NASDAQ">LTBR</a>) gained 15.1% to settle at $7.23.</li>
<li>Lightbridge recently received notice of acceptance for key patent in Australia.</li>
<li>TORM plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trmd#NASDAQ">TRMD</a>) rose 14.4% to close at $9.22.</li>
<li>LM Funding America, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmfa#NASDAQ">LMFA</a>) climbed 13.5% to settle at $5.39. LM Funding priced 6,315,780 unit offering at $4.75 per unit.</li>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) gained 13.4% to close at $63.52.</li>
<li>Xiaobai Maimai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hx#NASDAQ">HX</a>) surged 13.1% to settle at $6.67.</li>
<li>BTCS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcs#NASDAQ">BTCS</a>) gained 13% to close at $6.68.</li>
<li>TaskUs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/task#NASDAQ">TASK</a>) shares jumped 12.6% to settle at $72.92. TaskUs, after the closing bell, announced the launch of a secondary offering of 10 million shares of Class A common stock.</li>
<li>Greenpro Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grnq#NASDAQ">GRNQ</a>) gained 11.8% to close at $0.9994 after jumping around 19% on Friday.</li>
<li>DoubleVerify Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dv#NYSE">DV</a>) rose 11.3% to close at $35.36. Barclays maintained DoubleVerify with an Equal-Weight and lowered the price target from $42 to $37.</li>
<li>Ardmore Shipping Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asc#NYSE">ASC</a>) rose 10.6% to settle at $4.29.</li>
<li>InMed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inm#NASDAQ">INM</a>) shares gained 9.3% to close at $1.53. InMed Pharmaceuticals recently announced completion of BayMedica acquisition.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) climbed 9.3% to settle at $6.56.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 7% to close at $29.80 amid a weekend increase in the price of Bitcoin.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) shares tumbled 39.2% to close at $13.81 on Monday. The FDA issued a Complete Response Letter (CRL) regarding Revance Therapeutics&rsquo; marketing application for DaxibotulinumtoxinA for Injection for moderate to severe glabellar (frown) lines.</li>
<li>Omeros Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) fell 26.7% to close at $5.67 after the company announced it received a Complete Response Letter from the FDA for the Biologics License Application for narsoplimab in the treatment of HSCT-TMA.</li>
<li>Nxt-ID, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtd#NASDAQ">NXTD</a>) fell 20.9% to close at $3.13.</li>
<li>Jasper Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jspr#NASDAQ">JSPR</a>) dipped 18.7% to settle at $13.35 as the stock pulled back following last week&#39;s strength.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) fell 18.3% to close at $4.16 after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application for Tyvaso DPI.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) dipped 16.9% to settle at $2.61.</li>
<li>NextPlay Technologies&rsquo; co-CEO purchased 1.99 million shares at average price of $2 per share.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) dropped 16.4% to close at $2.90.</li>
<li>Kala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kala#NASDAQ">KALA</a>) fell 16.3% to close at $1.85.</li>
<li>Phathom Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phat#NASDAQ">PHAT</a>) fell 16.2% to close at $27.26. Phathom Pharmaceuticals announced data from the PHALCON-EE Phase 3 trial evaluating vonoprazan versus lansoprazole for erosive esophagitis (EE).</li>
<li>Cullinan Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgem#NASDAQ">CGEM</a>) fell 15.5% to close at $21.12. Cullinan Oncology named Nadim Ahmed as Chief Executive Officer.</li>
<li>Avadel Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avdl#NASDAQ">AVDL</a>) dipped 15.4% to settle at $8.45. Avadel Pharmaceuticals reported ongoing FDA review of NDA for FT218 for patients with narcolepsy.</li>
<li>Latch, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltch#NASDAQ">LTCH</a>) declined 14.7% to close at $9.31. Goldman Sachs downgraded Latch from Buy to Neutral and lowered the price target from $16 to $10.</li>
<li>NACCO Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nc#NYSE">NC</a>) fell 14.2% to settle at $32.99.</li>
<li>Renovacor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcor#NYSE">RCOR</a>) dropped 13.9% to close at $6.99.</li>
<li>Ionis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ions#NASDAQ">IONS</a>) fell 13.8% to close at $30.25. Ionis Pharmaceuticals recently highlighted topline results from its tofersen Phase 3 study and its open label extension in SOD1-ALS at the American Neurological Association Meeting.</li>
<li>Enzo Biochem, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/enz#NYSE">ENZ</a>) dipped 12.4% to settle at $3.31. Enzo Biochem recently reported fourth-quarter FY21 revenue growth of 27% year-on-year to $24.8 million.</li>
<li>Zillow Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/z#NASDAQ">Z</a>) shares fell 9.5% to close at $86.00. After buying more than 3,800 homes in the second quarter, Zillow Group has announced that it will make no further purchases for the rest of the year, according to a report from Bloomberg.</li>
<li>Salem Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/salm#NASDAQ">SALM</a>) fell 6.9% to settle at $3.25.</li>
<li>Flywire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flyw#NASDAQ">FLYW</a>) fell 6.7% to close at $48.37.</li>
</ul>

AGRX

AMPL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

Comments

Symbolic Logic

Symbolic Logic (EVOL) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL